1 |
Kwon, G. S. (2006) Polymeric Drug Delivery Systems, pp. 93-123. Taylor and Francis Group, LLC, Boca Paton, USA.
|
2 |
Nussbaumer, S., P. Bonnabry, J. L. Veuthey, and S. Fleury-Souverain (2011) Analysis of anticancer drugs: A review. Talanta 85: 2265-2289.
DOI
|
3 |
Nair, L. S. and C. T. Laurencin (2006) Polymers as biomaterials for tissue engineering and controlled drug delivery. Biochem. Eng. Biotechnol. 102: 47-90.
|
4 |
Feng, S. S. and S. Chien (2003) Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem. Eng. Sci. 58: 4087-4114.
DOI
ScienceOn
|
5 |
Ravi Kumar, M. N. V. and N. Kumar (2001) Polymeric controlled drug-delivery systems: Perspective issues and opportunities. Drug Dev. Ind. Pharm. 27: 1-30.
DOI
ScienceOn
|
6 |
Park, J., M. Ye, and K. Park (2005) Biodegradable polymers for microencapsulation of drugs. Molecules 10: 146-161.
DOI
ScienceOn
|
7 |
Wirk, B. and E. Perez (2006) Role of gemcitabine in breast cancer management: An update. Semin. Oncol. 33: 6-14.
|
8 |
Mangeold, C. (2001) Chemotherapy for advanced non-small cell lung cancer. Semin. Oncol. 28: 1-6.
DOI
|
9 |
Maase, H. V. D. (2001) Gemcitabine in advanced bladder canner. Semin. Oncol. 28: 11-14.
DOI
|
10 |
Fruscella, E., D. Gallo, G. Ferrandina, G. D'Agostino, and G. Scambia (2003) Gemcitabine: Current role and future options in the treatment of ovarian cancer. Crit. Rev. Oncol. Hematol. 48: 81-88.
DOI
ScienceOn
|
11 |
Jagur-Grodzinski, J. (2009) Polymers for targeted and/or sustained drug delivery. Polym. Adv. Technol. 20: 595-606.
DOI
|
12 |
Locher, C., E. Fabre-Guillevin, F. Brunetti, J. Auroux, J. C. Delchier, P. Piedbois, and L. Zelek (2008) Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: An observational study. Crit. Rev. Oncol. Hematol. 68: 178-182.
DOI
ScienceOn
|
13 |
Joo, H. J., I. I. Jung, G. B. Lim, and J. H. Ryu (2011) Production of gemcitabine-loaded poly(L-lactic acid) microparticles using supercritical carbon dioxide: Effect of process parameters. KSBB J. 26: 69-77.
과학기술학회마을
DOI
|
14 |
Zhigaltsev, I. V., N. Maurer, F. W. Kim, and P. R. Cullis (2002) Triggered release of doxorubicin following mixing of cationic and anionic liposomes. Biochem. Biophys. Acta 1565: 129-135.
DOI
|
15 |
Pasut, G. and F. M. Veronese (2007) Polymer-drug conjugation, recent achievements and general strategies. Prog. Polym. Sci. 32: 933-961.
DOI
ScienceOn
|
16 |
Vicent, M. J. (2007) Polymer-drug conjugates as modulators of cellular apoptosis. AAPS J. 16: E200-E207.
|
17 |
Satchi-Fainaro, R., R. Duncan, and C. M. Barnes (2006) Polymer therapeutics for cancer: Current status and future challenges. Adv. Polym. Sci. 193: 1-65.
DOI
|
18 |
Yeo, S. D. and E. Kiran (2005) Formation of polymer particles with supercritical fluids: A review. J. Supercrit. Fluids 34: 287-308.
DOI
ScienceOn
|
19 |
Jain, R. A. (2000) The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21: 2475-2490.
DOI
ScienceOn
|
20 |
Li, M., O. Rouaud, and D. Poncelet (2008) Microencapsulation by solvent evaporation: State of the art for process engineering approachs. Int. J. Pharm. 363: 26-39.
DOI
ScienceOn
|
21 |
Yoo, H. S. and T. G. Park (2004) Folate receptor targeted biodegradable polymeric doxorubicin micelles. J. Control. Rel. 96: 273-283.
DOI
ScienceOn
|
22 |
Bahrami, M. and S. Ranjbarian (2007) Production of micro- and nano-composite particles by supercritical carbon dioxide. J. Supercrit. Fluids 40: 263-283.
DOI
ScienceOn
|
23 |
Ryu, J. H. (2013) Synthesis of gemcitabine-PLLA conjugates and preparation of their microparticles using supercritical fluid. The University of Suwon Theses Collection 27: 149-155.
|
24 |
Jung, J. H., I. I. Jung, H. J. Joo, J. R. Shin, G. B. Lim, and J. H. Ryu (2008) Preparation of biodegradable polymer microparticles containing 5-FU using supercritical carbon dioxide. KSBB J. 23: 452-459.
과학기술학회마을
|
25 |
Espartero, J. L., I. Rashkov, S. M. Li, N. Manolova, and M. Vert (1996) NMR analysis of low molecular weight poly(lactic acid)s. Macromolecules 29: 3535-3539.
DOI
ScienceOn
|
26 |
Cavallaro, G., L. Mariano, S. Salmaso, P. Caliceti, and G. Gaetano (2006) Folate-mediated targeting of polymeric conjugates of gemcitabine. Int. J. Pharm. 307: 258-269.
DOI
|
27 |
Jung, J. and M. Perrut (2001) Particle design using supercritical fiuids: Literature and patent survey. J. Supercrit. Fluids 20: 179-219.
DOI
ScienceOn
|
28 |
Vandana, M. and S. K. Sahoo (2010) Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer. Biomaterials 31: 9340-9356.
DOI
|
29 |
Dorgan, J. R., J. Janzen, M. P. Clayton, S. B. Hait, and D. M. Knauss (2005) Melt rheology of variable L-content poly(lactic-acid). J. Rheol. 49: 607-619.
DOI
|
30 |
Kim, J. H., S. Y. Lee, B. Y. Kim, J. H. Ryu, and G. B. Lim (2003) Preparation of L-PLA microparticles using pure and cosolventmodified supercritical carbon dioxide. KSBB J. 18: 385-392.
|
31 |
Pasquali, I., R. Bettini, and F. Giordano (2008) Supercritical fluid technologies: An innovative approach for manipulating the solid-state of pharmaceuticals. Adv. Drug Del. Rev. 60: 399-410.
DOI
|
32 |
Bahrami, M. and S. Ranjbarian (2007) Production of micro- and nano-composite particles by supercritical carbon dioxide. J. Supercrit. Fluids 40: 263-283.
DOI
ScienceOn
|